vs

Side-by-side financial comparison of FIRST UNITED CORP (FUNC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $23.2M, roughly 1.6× FIRST UNITED CORP). On growth, FIRST UNITED CORP posted the faster year-over-year revenue change (11.9% vs -57.1%). Over the past eight quarters, FIRST UNITED CORP's revenue compounded faster (11.5% CAGR vs -46.5%).

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FUNC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.6× larger
ORGO
$37.2M
$23.2M
FUNC
Growing faster (revenue YoY)
FUNC
FUNC
+68.9% gap
FUNC
11.9%
-57.1%
ORGO
Faster 2-yr revenue CAGR
FUNC
FUNC
Annualised
FUNC
11.5%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FUNC
FUNC
ORGO
ORGO
Revenue
$23.2M
$37.2M
Net Profit
$5.8M
Gross Margin
30.8%
Operating Margin
32.9%
-185.1%
Net Margin
24.9%
Revenue YoY
11.9%
-57.1%
Net Profit YoY
-6.6%
EPS (diluted)
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FUNC
FUNC
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$23.2M
$225.6M
Q3 25
$22.7M
$150.9M
Q2 25
$21.8M
$101.0M
Q1 25
$20.9M
$86.7M
Q4 24
$20.8M
$126.7M
Q3 24
$20.3M
$115.2M
Q2 24
$20.1M
$130.2M
Net Profit
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
$5.8M
$43.7M
Q3 25
$6.9M
$21.6M
Q2 25
$6.0M
$-9.4M
Q1 25
$5.8M
$-18.8M
Q4 24
$6.2M
$7.7M
Q3 24
$5.8M
$12.3M
Q2 24
$4.9M
$-17.0M
Gross Margin
FUNC
FUNC
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
FUNC
FUNC
ORGO
ORGO
Q1 26
-185.1%
Q4 25
32.9%
28.1%
Q3 25
40.6%
13.7%
Q2 25
36.5%
-12.5%
Q1 25
36.8%
-30.9%
Q4 24
39.2%
8.1%
Q3 24
38.0%
5.4%
Q2 24
32.5%
-10.7%
Net Margin
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
24.9%
19.4%
Q3 25
30.6%
14.3%
Q2 25
27.5%
-9.3%
Q1 25
27.7%
-21.7%
Q4 24
29.8%
6.1%
Q3 24
28.5%
10.7%
Q2 24
24.5%
-13.1%
EPS (diluted)
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
$0.89
$0.31
Q3 25
$1.07
$0.11
Q2 25
$0.92
$-0.10
Q1 25
$0.89
$-0.17
Q4 24
$0.95
$0.05
Q3 24
$0.89
$0.09
Q2 24
$0.75
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FUNC
FUNC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$131.6M
$91.4M
Total DebtLower is stronger
$95.9M
Stockholders' EquityBook value
$203.6M
Total Assets
$2.1B
$520.0M
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FUNC
FUNC
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$131.6M
$93.7M
Q3 25
$95.2M
$63.7M
Q2 25
$79.1M
$73.1M
Q1 25
$84.4M
$110.0M
Q4 24
$78.3M
$135.6M
Q3 24
$62.4M
$94.3M
Q2 24
$45.1M
$89.9M
Total Debt
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
$95.9M
Q3 25
$95.9M
Q2 25
$120.9M
Q1 25
$120.9M
Q4 24
$120.9M
Q3 24
$120.9M
$62.3M
Q2 24
$70.9M
$63.8M
Stockholders' Equity
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
$203.6M
$300.1M
Q3 25
$199.1M
$255.1M
Q2 25
$191.1M
$233.2M
Q1 25
$183.7M
$242.9M
Q4 24
$179.3M
$262.9M
Q3 24
$174.0M
$278.5M
Q2 24
$164.2M
$263.5M
Total Assets
FUNC
FUNC
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$2.1B
$598.7M
Q3 25
$2.0B
$509.8M
Q2 25
$2.0B
$461.1M
Q1 25
$2.0B
$467.4M
Q4 24
$2.0B
$497.9M
Q3 24
$1.9B
$446.3M
Q2 24
$1.9B
$443.2M
Debt / Equity
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
0.47×
Q3 25
0.48×
Q2 25
0.63×
Q1 25
0.66×
Q4 24
0.67×
Q3 24
0.70×
0.22×
Q2 24
0.43×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FUNC
FUNC
ORGO
ORGO
Operating Cash FlowLast quarter
$19.4M
Free Cash FlowOCF − Capex
$15.4M
FCF MarginFCF / Revenue
66.3%
Capex IntensityCapex / Revenue
17.1%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$22.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
$19.4M
$39.4M
Q3 25
$1.5M
$3.1M
Q2 25
$995.0K
$-32.9M
Q1 25
$7.0M
$-19.9M
Q4 24
$22.3M
$10.9M
Q3 24
$2.3M
$8.7M
Q2 24
$7.2M
$4.7M
Free Cash Flow
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
$15.4M
$34.8M
Q3 25
$168.0K
$844.0K
Q2 25
$706.0K
$-36.5M
Q1 25
$6.4M
$-23.6M
Q4 24
$20.4M
$7.6M
Q3 24
$588.0K
$6.1M
Q2 24
$7.0M
$2.9M
FCF Margin
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
66.3%
15.4%
Q3 25
0.7%
0.6%
Q2 25
3.2%
-36.1%
Q1 25
30.5%
-27.2%
Q4 24
98.1%
6.0%
Q3 24
2.9%
5.3%
Q2 24
35.1%
2.2%
Capex Intensity
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
17.1%
2.1%
Q3 25
5.9%
1.5%
Q2 25
1.3%
3.6%
Q1 25
2.8%
4.2%
Q4 24
9.3%
2.7%
Q3 24
8.4%
2.2%
Q2 24
0.6%
1.4%
Cash Conversion
FUNC
FUNC
ORGO
ORGO
Q1 26
Q4 25
3.35×
0.90×
Q3 25
0.22×
0.14×
Q2 25
0.17×
Q1 25
1.20×
Q4 24
3.60×
1.43×
Q3 24
0.40×
0.71×
Q2 24
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons